Skip to main contentSkip to page footer

Selected References

Selected References (last five years)

  • Korn K, Steininger P, Schmidt B, Thoma-Kress AK, Forneck L, Knöll A. (2026) Experiences from Two Decades of HTLV-1/2 Testing in a Low-Prevalence Area in Southern Germany, 2004 to 2024. Viruses, 18(08), 882. doi:10.3390/v18080882.

  • Birzer A, Drassner C, Muehl-Zuerbes P, Kuhnt C, Krawczyk A, Thoma-Kress AK, Steinkasserer A, Popella L. (2026) Herpes simplex virus type 1 interferes with signal transducer and activator of transcription 3 expression in infected mature dendritic cells. J Gen Virol 107(8):002280. doi: 10.1099/jgv.0.002280.

  • Simon F, Donhauser N, Kemeter LM, Wittdorf F, Millen S, Sticht H, Thoma-Kress AK. (2025) Inhibition of the signal peptidase complex blocks cleavage of HTLV-1 ORFI-encoded p12 to p8 and impairs p8-dependent virus transmission. PLoS Pathogens 21(10): e1013570. doi: 10.1371/journal.ppat.1013570.

  • Heym S, Krebs P, Ott K, Donhauser N, Kemeter LM, Simon F, Millen S, Thoma-Kress AK (2024). A Novel Tax-Responsive Reporter T-Cell Line to Analyze Infection of HTLV-1. Pathogens, 13(11), 1015. doi:10.3390/pathogens13111015.

  • Kohrt S, Baheerathan A, Prokscha J, Zwosta A, Sticht H, Thoma-Kress AK (2024) Identification of a nuclear localization signal (NLS) in human transcription elongation factor ELL2. Cell Biochem Funct., 42(8):e70019. doi:10.1002/cbf.70019.

  • Zeyn Y, Hobernik D, Wilk U, Pöhmerer J, Hieber C, Medina-Montano C, Röhrig N, Strähle CF, Thoma-Kress AK, Wagner E, Bros M*, Berger S* (2023) Transcriptional Targeting of Dendritic Cells Using an Optimized Human Fascin1 Gene Promoter. Int. J. Mol. Sci. 24(23):16938. doi.org/10.3390/ijms242316938. *corresponding authors.

  • Rojo-Romanos T, Karpinski J, Millen S, Beschorner N, Simon F, Paszkowski-Rogacz M, Lansing F, Schneider PM, Sonntag J, Hauber J, Thoma-Kress AK, Buchholz F (2023) Precise excision of HTLV-1 provirus with a designer-recombinase. Mol. Therapy S1525-0016(23)00135-1. doi: 10.1016/j.ymthe.2023.03.014. 

  • Schnell AP, Kohrt S, Aristodemou A, Taylor GP, Bangham CRM, Thoma-Kress AK (2022) HDAC inhibitors Panobinostat and Romidepsin enhance tax transcription in HTLV-1-infected cell lines and freshly isolated patients' T-cells. Front. Immunol. 13:978800. doi: 10.3389/fimmu.2022.978800.

  • Heym S, Mohr CF, Engelbrecht HC, Fleckenstein B, Thoma-Kress AK (2022) Alternative NF-κB Signaling Discriminates Induction of the Tumor Marker Fascin by the Viral Oncoproteins Tax-1 and Tax-2 of Human T-Cell Leukemia Viruses. Cancers 14(3):537. doi: 10.3390/cancers14030537. 

  • Kohrt S, Strobel S, Mann MC, Sticht H, Fleckenstein B, Thoma-Kress AK (2021) Characterizing the Interaction between the HTLV-1 Transactivator Tax-1 with Transcription Elongation Factor ELL2 and Its Impact on Viral Transactivation. Int. J. Mol. Sci. 2(24), 13597; doi: 10.3390/ijms222413597. 

Selected Reviews and Book Chapters (last five years)

  • Simon F, Thoma-Kress AK (2024) Intercellular transport of viral proteins. Editors: Jacek Z. Kubiak, Malgorzata Kloc. Springer Nature. Results Probl Cell Differ. 73:435-474. doi: 10.1007/978-3-031-62036-2_18.

  • de Mendoza C, Taylor G, Gessain A, Thoma-Kress AK, Bangham C, Vesterbacka J, Accolla R, Bazarbachi A, van Weyenbergh J, Cook L, Casseb J, Ramos JC, Rosadas C, Macchi B, Cassar O, Soriano V. (2024) Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023). NeuroImmune Pharmacol. Ther. https://doi.org/10.1515/nipt-2023-0025

  • Kemeter L, Birzer A, Heym S, Thoma-Kress AK (2023) Milk transmission of mammalian retroviruses. Microorganisms. 11(7):1777. doi: 10.3390/microorganisms11071777. 

  • Millen S, Thoma-Kress AK (2022) Milk Transmission of HTLV-1 and the need for innovative prevention strategies. Front Med. 9:867147. doi: 10.3389/fmed.2022.867147.